Skip to main content

Bausch Health Companies Inc(BHC-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Bausch Health Companies Inc down on Monday (BHC)

Automated Summaries - The Globe and Mail - Mon Apr 8, 4:02PM CDT

Bausch Health Companies Inc opened trading today at $14.21 and closed at $13.17. It traded at a low of $12.71 to a high of $14.21.

Shares dipped -6.93 percent from the previous day's close of $14.15.

During the day across North America, the TSX Composite closed 0.96% at 22264.38, the S&P 500 closed 1.11% at 5204.34, the Dow Jones Industrial Average closed 0.80% at 38904.04 and the Nasdaq Composite closed 1.24% at 16248.52.

Bausch Health Companies Inc has listed on the Toronto Stock Exchange (TSX) under the ticker BHC.

A total of 733,748 shares was traded during the session, with total trades of 4,948, with an average volume of 488,450 over 5 days.

The TSX market on the whole today saw 3,142 price advancers against 2,094 declines and 118 unchanged.

During the prior 52 weeks, BHC.TO has traded as high as $15.43 (April 03,2024) and low as $7.56 (May 12,2023). Moreover, the shares have boosted 33.30 percent in 52 weeks, while in 2024, they have advanced 23.89%.

It announced a 1.00 dividend on November 05/10, with an November 10/10 ex-date and December 22/10 pay day.

Following today's trading, Bausch Health Companies Inc has a market capitalization of $5.17 billion on a float of 365,412 shares outstanding. Its annual EPS is $-1.62.

Bausch Health Companies Inc is a TSX Drug Specialty & Generic company headquartered in Laval, CAN.

Bausch Health Companies Inc's average recommendation is "Hold" based on 6.00 analysts according to Zacks. Currently, there are 1 buy ratings, 1 sell ratings and 4 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe